Agios Pharmaceuticals (AGIO) Competitors $40.00 -0.35 (-0.87%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$40.29 +0.29 (+0.73%) As of 07/18/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AGIO vs. BBIO, BPMC, VRNA, ROIV, ELAN, RVMD, LEGN, GRFS, TGTX, and NUVLShould you be buying Agios Pharmaceuticals stock or one of its competitors? The main competitors of Agios Pharmaceuticals include BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Legend Biotech (LEGN), Grifols (GRFS), TG Therapeutics (TGTX), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. Agios Pharmaceuticals vs. Its Competitors BridgeBio Pharma Blueprint Medicines Verona Pharma PLC American Depositary Share Roivant Sciences Elanco Animal Health Revolution Medicines Legend Biotech Grifols TG Therapeutics Nuvalent Agios Pharmaceuticals (NASDAQ:AGIO) and BridgeBio Pharma (NASDAQ:BBIO) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk. Which has higher valuation and earnings, AGIO or BBIO? Agios Pharmaceuticals has higher earnings, but lower revenue than BridgeBio Pharma. BridgeBio Pharma is trading at a lower price-to-earnings ratio than Agios Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgios Pharmaceuticals$36.50M63.47$673.72M$11.243.56BridgeBio Pharma$221.90M39.80-$535.76M-$3.53-13.18 Do analysts recommend AGIO or BBIO? Agios Pharmaceuticals currently has a consensus target price of $58.60, indicating a potential upside of 46.50%. BridgeBio Pharma has a consensus target price of $61.20, indicating a potential upside of 31.58%. Given Agios Pharmaceuticals' higher probable upside, analysts plainly believe Agios Pharmaceuticals is more favorable than BridgeBio Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agios Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71BridgeBio Pharma 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, AGIO or BBIO? Agios Pharmaceuticals has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500. Comparatively, BridgeBio Pharma has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Does the media prefer AGIO or BBIO? In the previous week, BridgeBio Pharma had 14 more articles in the media than Agios Pharmaceuticals. MarketBeat recorded 25 mentions for BridgeBio Pharma and 11 mentions for Agios Pharmaceuticals. BridgeBio Pharma's average media sentiment score of 0.41 beat Agios Pharmaceuticals' score of 0.14 indicating that BridgeBio Pharma is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agios Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BridgeBio Pharma 7 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is AGIO or BBIO more profitable? Agios Pharmaceuticals has a net margin of 1,798.26% compared to BridgeBio Pharma's net margin of -524.25%. BridgeBio Pharma's return on equity of 0.00% beat Agios Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Agios Pharmaceuticals1,798.26% -2.75% -2.52% BridgeBio Pharma -524.25%N/A -94.43% Do insiders and institutionals hold more shares of AGIO or BBIO? 99.9% of BridgeBio Pharma shares are held by institutional investors. 4.3% of Agios Pharmaceuticals shares are held by company insiders. Comparatively, 18.2% of BridgeBio Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryBridgeBio Pharma beats Agios Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Get Agios Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AGIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGIO vs. The Competition Export to ExcelMetricAgios PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.34B$2.95B$5.54B$9.40BDividend YieldN/A2.44%3.75%4.03%P/E Ratio3.5619.7528.0119.77Price / Sales63.47298.28432.5597.25Price / CashN/A42.5936.1658.27Price / Book1.487.678.125.65Net Income$673.72M-$55.28M$3.25B$257.91M7 Day Performance2.43%4.85%1.64%3.35%1 Month Performance12.68%11.70%7.27%11.09%1 Year Performance-14.18%3.69%32.88%18.99% Agios Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGIOAgios Pharmaceuticals4.3967 of 5 stars$40.00-0.9%$58.60+46.5%-16.1%$2.34B$36.50M3.56390BBIOBridgeBio Pharma4.6157 of 5 stars$43.50-1.1%$58.85+35.3%+79.4%$8.35B$221.90M-12.32400Analyst RevisionBPMCBlueprint Medicines1.0851 of 5 stars$128.40+0.0%$128.06-0.3%+14.1%$8.29B$508.82M-51.98640News CoverageAnalyst UpgradeVRNAVerona Pharma PLC American Depositary Share2.3966 of 5 stars$91.20-0.4%$107.36+17.7%+364.6%$7.79B$42.28M-45.6030ROIVRoivant Sciences2.7193 of 5 stars$10.74-2.3%$17.50+62.9%+3.0%$7.47B$29.05M-42.96860ELANElanco Animal Health2.0442 of 5 stars$14.48-1.1%$15.33+5.9%+14.8%$7.27B$4.44B19.579,000Analyst UpgradeAnalyst RevisionRVMDRevolution Medicines4.5461 of 5 stars$36.67-3.2%$67.58+84.3%-16.8%$7.05B$11.58M-9.17250Analyst ForecastLEGNLegend Biotech3.6948 of 5 stars$35.87+0.6%$72.60+102.4%-28.6%$6.55B$627.24M-60.802,609News CoverageAnalyst ForecastAnalyst RevisionGRFSGrifols3.5357 of 5 stars$8.87-2.3%$10.30+16.1%+22.4%$6.24B$7.81B7.5823,822News CoverageTGTXTG Therapeutics3.6841 of 5 stars$35.98-2.0%$40.80+13.4%+78.6%$5.83B$329M149.92290Positive NewsNUVLNuvalent3.3316 of 5 stars$77.93-3.2%$119.60+53.5%+4.5%$5.78BN/A-17.7540Insider Trade Related Companies and Tools Related Companies BridgeBio Pharma Alternatives Blueprint Medicines Alternatives Verona Pharma PLC American Depositary Share Alternatives Roivant Sciences Alternatives Elanco Animal Health Alternatives Revolution Medicines Alternatives Legend Biotech Alternatives Grifols Alternatives TG Therapeutics Alternatives Nuvalent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AGIO) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agios Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agios Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AGIO Stock Alerts